Effects of cyclosporine on adriamycin induced nephropathy

Nephrology

Volumn 4, Issue 5-6, 1998, Pages 385-389

  Soares, Vitor A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Adriamycin nephropathy; Cyclosporine; Glomerulosclerosis; Nephrotic syndrome; Proteinuria

Indexed keywords

CYCLOSPORIN A; DOXORUBICIN;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; GLOMERULOSCLEROSIS; KIDNEY DISEASE; KIDNEY MASS; MALE; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

EID: 0032453728     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1998.tb00376.x     Document Type: Article

References (20)

1. 1. Tipping PC, Neale JT, Holdsworth SR. T lymphocyte participation in antibody induced experimental glomerulonephritis. Kidney Int. 1985; 27: 530-7.
2. 2. Cattran DC. Effect of ciclosporin on active Heymann nephritis. Nephron 1988; 48: 142-8.
3. 3. Neild GH, Ivory K, Hiramatsu M, Williams DG. Cyclosporin A inhibits acute serum sickness nephritis in rabbits. Clin Exp. Immunol. 1983; 52: 586-94.
4. 4. Shibasaki T, Matsuda H, Nakano H, Masumoto H, Miyahara, T. Effects of cyclosporine on puromycin aminonucleoside-induced nephrotic rats. J. Chemother. 1989; 1: 211-5.
5. 5. Kokui K, Yoshikawa N, Nakamura H, Itoh H. Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis. J. Pathol. 1992; 166: 297-301.
6. 6. Nahmann NS, Cosio FG. The effects of ciclosporin in experimental glomerulosclerosis. Nephron 1990; 56: 414-20.
7. 7. Desasis JF, Raats CJI, Bakker MAH, van den Born J, Berden JHM. Antiproteinuric effect of ciclosporin A in adriamycin nephropathy in rats. Nephron 1997; 75: 336-41.
8. 8. Meyrier A. Antiproteinuric and immunological effects of cyclosporine A in the treatment of glomerular diseases. Nephrol. Dial. Transplant. 1992; 7 (Suppl. 1): S80-4.
9. 9. Myers BD, Ross J, Newton L, Luetscher J, Perlroth, M. Cyclosporine-associated chronic nephropathy. N. Engl. J. Med. 1984; 311: 699-705.
10. 10. Palestine AG, Austin HA, Balow JE et al. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N. Engl. J. Med. 1986; 314: 1293-8.
11. 11. Nahman NS Jr, Cosio FG, Kolkin S, Mendell JR, Sharma HM. Cyclosporine nephrotoxicity without major organ transplantation. Ann. Intern. Med. 1987; 106: 400-2.
12. 12. Fries JWU, Sandstrom DJ, Meyer TW, Rennke H. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab. Invest. 1989; 60: 205-18.
13. 13. Giles KW, Myers A. An improved diphenilalanine method for the estimation of deoxyribonucleic acid. Nature 1965; 206: 93.
14. 14. Munro HN, Fleck A. The determination of nucleic acid. Methods Biochem. Anal. 1966; 14: 114-76.
15. 15. Lowry OH, Roesbrough NJ, Farr AL. Protein measurement with the Follin phenol reagent. J. Biol. Chem. 1951; 193: 265-75.
16. 16. Switzer BR. Determination of hydroxyproline in tissue. J. Nutr. Biochem. 1991; 2: 229-31.
17. 17. Gomez-Chiari M, Ortiz A, Lerma JL et al. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Lab. Invest. 1994; 70: 449-59.
18. 18. Gomez-Chiari M, Ortiz A, Lerma JL, Gonzalez E, Egido J. Low protein diet modifies proteinuria and glomerular production of inflammatory mediators in a experimental nephritis. J. Am. Soc. Nephrol. 1991; 2: 542.
19. 19. Stiller CR, Keown PA. Cyclosporine therapy in perspective. In: Morris P.G., Tilney N.L. (eds) Progress in Transplantation. Churchill Livingstone, New York, 1984; 11-45.
20. 20. Araujo CG, Trindade JCS, Bastos HD, Lautschlenger MF. Cyclofosfamide and inhibition of renal compensatory hypertrophy. Braz. J. Med. Biol. Res. 1985; 18: 533-39.